Summary:
A multicenter, randomized, double-blind, placebo-controlled, relapse prevention study with vilazodone in patients with major depressive disorder.
Qualified Participants Must:
• Be between 18 and 70 years of age
•
Currently meet the DSM-IV-TR criteria for Major Depressive Disorder
•
Have had a major depressive episode that lasted at least 8 weeks and no longer than 18 months in duration
Qualified Participants May Receive:
Compensation, mental evaluations, physical exam.